Postgraduate Training Course in Reproductive Health/Chronic Disease
Table 3 : On-going IARC collaborative studies on VIA for cervical cancer screening (32)
Program design | Interventions evaluated | Location of the study | Number of participants | End points of the program |
Randomised, controlled intervention study | VIA, cervical cytology, HPV testing | Osmanabad district, India | 160,000 women 30-59 years | Cervical cancer incidence/ mortality; Cost-effectiveness; establishment of a service and training platform for cervical cancer prevention. |
Randomised, controlled intervention study | VIA | Dindigul District, India | 73,000 women aged 30-59 years | Detection rates of CIN2-3Cervical cancer incidence/mortality; Cost-effectiveness; establishment of a service and training platform for cervical cancer prevention. |
Cross-sectional study | VIA, VILI | Burkina Faso, Republic of Congo, Guinea, Hyderabad, India, Laos, Mali, Niger, Mauritania, Tanzania | 5000 women aged 30-59 in each location | Test characteristics; Acceptability, efficacy, complications of cryotherapy; establishment of a service and training platform for cervical cancer prevention. |
Cross-sectional study | VIA, cytology | Nigeria | 2000 women aged 30-64 years | Test characteristics; Acceptability, efficacy, complications of cryotherapy; establishment of a service and training platform for cervical cancer prevention. |
Cross-sectional study | VIA, VILI, cervical cytology | Trivandrum and Jaipur India | 6000 women 30-59 years in each location | Test characteristics; Acceptability, efficacy, complications of cryotherapy; establishment of a service and training platform for cervical cancer prevention. |
Cross-sectional study | VIA, VIAM, VILI, cervical cytology, HPV testing | Calcutta, India | 12,000 women aged 30-64 years | Test characteristics; Acceptability, efficacy, complications of cryotherapy; establishment of a service and training platform for cervical cancer prevention. |
Cross sectional study | Cervical cytology, HPV testing, VIA, VIAM, VILI | Bombay, India | 5000 women aged 30-59 years | Test characteristics; Acceptability, efficacy, complications of cryotherapy; establishment of a service and training platform for cervical cancer prevention. |